A CKD patient presents with potassium 5.9 mEq/L. What immediate management steps should be taken to stabilize the myocardium?

• A. IV calcium gluconate to stabilize cardiac membranes, followed by insulin with glucose and/or beta-agonist therapy; monitor ECG and prepare for dialysis if refractory
• B. Oral bicarbonate therapy to correct acidosis
• C. Oral potassium binders only
• D. Fluid restriction and observation

Answer: (A)

When potassium is markedly elevated and the heart is at risk, the first priority is to protect cardiac membranes. IV calcium gluconate rapidly stabilizes the myocardial cell membranes, reducing excitability and preventing life-threatening arrhythmias, even before any change in serum potassium occurs. After the heart is stabilized, the next step is to lower the extracellular potassium by shifting it into cells—administer insulin with glucose, and/or a beta-agonist such as albuterol. These moves can rapidly decrease potassium levels within minutes to an hour. Continuous ECG monitoring is essential during this process to track response and catch any evolving changes.

Bicarbonate can be helpful if metabolic acidosis is present, but it does not provide the immediate membrane stabilization that calcium does. Oral potassium binders act more slowly and are not used for immediate stabilization. Fluid restriction and observation do not address the urgent risk of arrhythmia in this scenario. In a CKD patient with significant hyperkalemia, dialysis is considered if potassium remains high or if there are ongoing risks or refractory cases, as it provides definitive potassium removal.